NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE American · Aerospace & Defense · USD

BiomX Inc. (PHGE) Stock Analysis

BiomX Inc. (PHGE) is a Aerospace & Defense stock listed on NYSE American and quoted in US Dollar.

PHGE

$0.15

+$0.01 (+4.23%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PHGE with… →

PHGE Key Statistics

As of Sep 4, 2026
Trading
Open
$0.14
Previous Close
$0.14
Day's Range
0.14–0.15
52-Week Range
0.12–12.29
Volume
1.97M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.34
Valuation
Market Cap
$3.95M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
11.89
EPS (ttm)Profit attributable to each share over the last twelve months.
−16.84
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$36.20M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
26.72M
1-Year Return
−98.49%
Dividend and dates
Earnings Date
November 11, 2026estimated
Avg Volume
2.98M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

PHGE Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−92.09%
2025−86.52%
2024−73.93%
2023+49.73%
2022−88.31%
2021−74.92%
2020−34.12%
2019 (partial year)+0.36%

As of September 4, 2026.

PHGE Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$36.20M—
2024$0.00−$17.73M—
2023$0.00−$26.17M—
2022$0.00−$28.32M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$30.92M−$36.20M—
2024$0.00—−$35.55M−$17.73M—
2023$0.00—−$25.35M−$26.17M—
2022$0.00—−$27.22M−$28.32M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PHGE Valuation vs Aerospace & Defense Median

Median of 97 stocks
MetricPHGEAerospace & Defense medianvs median
P/S ratio11.893.99198% above
Profit margin0.00%2.24%2.2 pts below

Medians across 97 Aerospace & Defense stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

BiomX Inc. (PHGE) is capitalised at $3.95M on the latest close. The company sits in the Industrials sector, in the Aerospace & Defense industry. The company reports 20 employees.

The 52-week range on file runs from $0.12 to $12.29. PHGE last closed at $0.15 on September 4, 2026. That is +$0.01 (+4.23%) against the previous close. The latest close sits 24.37% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $0.00. The same year closed with a net loss of $36.20M. Profit margin runs at 0%. That is 2.2 percentage points below the Aerospace & Defense median of 2.24%. Earnings per share on a trailing basis come to −16.84.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 11.89 times revenue. On price-to-sales that is 198.15% above the Aerospace & Defense median of 3.99. 97 Aerospace & Defense companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.34. Annualized volatility over the trailing 7 years is 142.75%. Over the trailing twelve months the price has returned −98.49%. Across 5 years the annualized return works out at −81.40%.

Growth & Income

The record shows no dividend for PHGE.

Across the complete calendar years on file, 2023 returned +49.73% and 2022 returned −88.31%. Of the 6 complete calendar years on file, 1 finished higher. 2026 is still running; the price is −92.09% year to date.

Peer Comparison

BiomX Inc. (PHGE) operates in the Aerospace & Defense industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
BiomX Inc. PHGE $3.95M —
Space Exploration Technologies Corp. SPCX $1.95T —
GE Aerospace GE $349.78B 39.8
RTX Corporation RTX $270.62B 35.4

The Aerospace & Defense industry average P/E ratio is 35.4x. BiomX Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Aerospace & Defense Stocks

SPCX

Space Exploration Technologies Corp.

$1.95T

 GE

GE Aerospace

$349.78B

 RTX

RTX Corporation

$270.62B

 BA

The Boeing Company

$167.76B

 LMT

Lockheed Martin Corporation

$121.23B

 HWM

Howmet Aerospace Inc.

$103.40B
View all Aerospace & Defense stocks →

Popular Industrials Stocks

CAT

Caterpillar Inc.

$374.15B

 GEV

GE Vernova Inc.

$250.87B

 DE

Deere & Company

$186.99B

 UNP

Union Pacific Corporation

$172.06B

 ETN

Eaton Corporation plc

$159.57B
View all Industrials stocks →

About BiomX Inc.

BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware.

Visit website →